BioCentury | May 7, 2016
Financial News

ACT Genomics raises $12.5M series B

Diagnostics developer ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $12.5 million in a series B round led by Hotung Group and CDIB Capital Management. Existing investors including the Eminent II fund of TaiAn Technologies,...
BioCentury | Oct 15, 2012
Company News

Compendia Bioscience, Life Technologies deal

...its plan to move into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc....
BioCentury | Oct 15, 2012
Finance

Highlights of weekly biotech stock moves

...a plan to move into cancer diagnostics that began in July with the acquisitions of Pinpoint Genomics Inc....
BioCentury | Oct 9, 2012
Company News

Life Tech acquires bioinformatics firm Compendia

...its plan to move into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc....
BioCentury | Oct 1, 2012
Company News

Life Technologies sales and marketing update

...at Life Technologies' CLIA-certified laboratory. The company gained the assay through its July acquisition of Pinpoint Genomics Inc....
BioCentury | Feb 6, 2012
Clinical News

Pinpoint Dx Lung Assay diagnostic data

...of blinded validation studies in FFPE tumor samples from patients with non-squamous NSCLC showed that Pinpoint Genomics'...
...Lancet. The test is available through Pinpoint Genomics' CLIA-certified laboratory in most states in the U.S. Pinpoint Genomics Inc....
BioCentury | Feb 6, 2012
Company News

Pinpoint Genomics sales and marketing update

...removal surgery. The assay measures the activity levels of 14 genes within a tumor sample. Pinpoint Genomics Inc....
Items per page:
1 - 7 of 7
BioCentury | May 7, 2016
Financial News

ACT Genomics raises $12.5M series B

Diagnostics developer ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $12.5 million in a series B round led by Hotung Group and CDIB Capital Management. Existing investors including the Eminent II fund of TaiAn Technologies,...
BioCentury | Oct 15, 2012
Company News

Compendia Bioscience, Life Technologies deal

...its plan to move into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc....
BioCentury | Oct 15, 2012
Finance

Highlights of weekly biotech stock moves

...a plan to move into cancer diagnostics that began in July with the acquisitions of Pinpoint Genomics Inc....
BioCentury | Oct 9, 2012
Company News

Life Tech acquires bioinformatics firm Compendia

...its plan to move into cancer diagnostics, which began in July with the acquisitions of Pinpoint Genomics Inc....
BioCentury | Oct 1, 2012
Company News

Life Technologies sales and marketing update

...at Life Technologies' CLIA-certified laboratory. The company gained the assay through its July acquisition of Pinpoint Genomics Inc....
BioCentury | Feb 6, 2012
Clinical News

Pinpoint Dx Lung Assay diagnostic data

...of blinded validation studies in FFPE tumor samples from patients with non-squamous NSCLC showed that Pinpoint Genomics'...
...Lancet. The test is available through Pinpoint Genomics' CLIA-certified laboratory in most states in the U.S. Pinpoint Genomics Inc....
BioCentury | Feb 6, 2012
Company News

Pinpoint Genomics sales and marketing update

...removal surgery. The assay measures the activity levels of 14 genes within a tumor sample. Pinpoint Genomics Inc....
Items per page:
1 - 7 of 7